Q32 Bio Inc. (FIXX) Net margin 2018–2025
Q32 Bio Inc. (FIXX) net profit margin by fiscal year — reported net income divided by reported revenue.
55.5%FY2025 · since FY2018: -1044.3% → 55.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 55.5% | — |
| FY2023 | -4649.0% | -4493.0 pp |
| FY2022 | -156.0% | +125.9 pp |
| FY2021 | -281.9% | +4481.0 pp |
| FY2020 | -4762.9% | +1474.5 pp |
| FY2019 | -6237.5% | -5193.2 pp |
| FY2018 | -1044.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice